Dana, N. et al. 2019. PPAR γ agonist, pioglitazone, suppresses melanoma cancer in mice by inhibiting TLR4 signaling. Journal of Pharmacy & Pharmaceutical Sciences. 22, 1 (Sep. 2019), 418–423. DOI:https://doi.org/10.18433/jpps30626.